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Genomic replication is possibly the most crucial process to the perpetuation of any 
species.  For cellular organisms, from E. Coli to Homo sapiens, this involves the copying 
of DNA by a class of extremely accurate and processive replicative enzymes: 
polymerases.  Many replicative polymerases have error rates of 10-3 to 10-6, 
misincorporating a nucleotide only once every 1,000 to 1,000,000 incorporation events.  
It is currently believed that there is very little ∆G˚ difference between the formation of 
correct and incorrect base pairs, and that the polymerase must somehow greatly amplify 
this ∆∆G˚ to achieve high levels of fidelity.  Current views on the matter stem from 
melting studies of DNA duplexes containing correct or incorrect base pairs at their 
termini, which only provide an approximation of base pair stability.  We have directly 
measured ∆G˚ for the incorporation of correct as well as incorrect nucleotides and found 
∆∆G˚ to be large enough to account for error rates as high as 10-5.  Our data indicate that 
the energetics of base pairing can account for high levels of fidelity with little if any 
∆∆G˚ amplification by the polymerase. 
 
The influenza virus, a non-cellular organism, encodes a multi-functional RNA-dependent 
RNA polymerase that both replicates its RNA genome as well as transcribes viral mRNA.  
 iv
Genomic replication occurs de novo, while transcription requires the polymerase to 
utilize its 7-methlyguanosine 5’ cap binding and endonuclease functions to “steal” a 5’ 
capped segment from a host transcript before it can polymerize influenza mRNA directly 
on to the 3’ end of the stolen segment.  A fundamental question of influenza pathology is 
how the polymerase begins transcribing mRNA at the early stages of influenza infection 
and switches to replication during the later stages.  We have identified the host 7-
methylguanosine 5’ cap source as well as the viral polymerase and template as factors 
that initiate a switch between transcription and replication.   
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The energetics of base pairing can account for high levels of polymerase fidelity: 
DNA replication is a process vital to all cellular organisms.  Prior to cellular division 
DNA polymerases must copy the cell’s DNA with a high degree of accuracy, on average 
making a mistake only once every 103 to 106 bases copied [1].  A combination of 
mismatch repair enzymes and 3’ → 5’ proofreading exonucleases can bring the overall 
error frequency of DNA replication to 10-9, one mutation for every billion incorporation 
events [2].  Inaccurate replication can lead to a variety of diseases, most notably cancer.  
Due to the critical nature of their activities polymerases have proven excellent drug 
targets [3].  Continued study of polymerases will enhance our knowledge of disease 
pathology and lead to the design of more effective therapeutics.   
 
The majority of replication fidelity occurs during the initial polymerization event [2].   
Polymerization of a single dNTP takes place through a multistep mechanism that is 
conserved throughout the majority of studied polymerases and is depicted in Figure 1 [3-
7].  The polymerase first binds DNA (step 1) before conjugating with a dNTP to form a 
ternary complex (step 2).  Following the formation of the ternary complex the enzyme 
undergoes a non-chemical step believed to be a conformational change (step 3), the exact 
identity of this non-chemical step is currently in dispute [8, 9].  After the conformational 
change a chemical step takes place in which the 3’ hydroxyl of DNAn’s primer strand 
performs a nucleophilic attack on the α-phosphate of the incoming dNTP resulting in the 
formation of pyrophosphate (PPi) and DNAn+1 (step 4).  A second conformational change 
takes place (step 5), following which PPi can be released from the E•DNAn+1 complex 
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Figure 1. Mechanism of DNA Polymerase. Step 1) Enzyme binding DNA. Step 2) 
Binding of dNTP forms ternary complex. Step 3) Enzyme undergoes a conformational 
change. Step 4) Phosphoryl transfer. Step 5) Enzyme returns to its initial state after a 
second conformational change. Step 6) Release of pyrophosphate. At this point the 
polymerase can either Step 7) polymerize another dNTP or Step 8) dissociate from the 
DNA. 
E + DNAn          E•DNAn + dNTP          E•DNAn•dNTP          E*•DNAn•dNTP          E*•DNAn+1•PPi                         
                                  E + DNAn+1           E•DNAn+1 + PPi           E•DNAn+1•PPi           
 
1 2 3 4 
5 6 8 
7 
(step 6).  At this point the enzyme can dissociate from DNAn+1 (step 8) or the polymerase 
can resample the dNTP pool and processively polymerize the next nucleotide (step 7).   
 
Following the binding of DNA each step along the polymerization pathway can provide 
the polymerase with an opportunity to discriminate between the formation of correct and 
incorrect base pairs.  The polymerase’s maximum fidelity is defined by the difference 
between the transition states of the rate-limiting steps for correct and incorrect 
incorporation.   The position along the pathway where fidelity is displayed varies 
between polymerases [5, 6, 8, 10, 11].  Studies of Klenow Fragment indicate that the rate-
limiting step of DNA polymerase I for correct incorporation is the conformational change 
preceding chemistry (Figure 1, step 3) while chemistry (step 4) is rate limiting for 
misincorporation on the same enzyme.  The energy difference between the transition 
states of step 3 for correct incorporation and step 4 for misincorporation accounts for the 
maximum fidelity of DNA polymerase I.  In contrast, work with the T7 DNA polymerase 
provides evidence that the conformational change remains rate limiting for both correct 
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as well as incorrect incorporation events and that the difference between the correct 
incorporation and the misincorporation transition states of step 3 accounts for maximum 
fidelity.  
  
The formation of an incorrect base pair significantly slows the rate of a subsequent 
polymerization event [5, 12, 13].  This stall provides a chance for the mispaired DNA to 
1) partially melt, allowing the transfer of the primer terminus to an intrinsic exonuclease 
site, should the polymerase contain one or 2) dissociate from the enzyme allowing the 
mismatched DNA the opportunity to re-associate with a polymerase containing a 3’ → 5’ 
exonuclease [14].  Exonucleolytic editing of DNAn+1 yields dNMP and a DNAn 
containing a primer terminus with a free 3’ hydroxyl group, affording the polymerase a 
second chance at polymerization of the correct dNTP.    
 
It is clear that different polymerases express varying levels of fidelity at different steps 
along their mechanistic pathway.  Where polymerases obtain the energy for 
discrimination has long puzzled researchers.  Current dogma postulates that there is very 
little energy difference between the formation of correct and incorrect base pairs (∆∆G˚ = 
0.2-3.0 kcal/mol) and that the polymerase must amplify this energy (up to 4.2-8.5 
kcal/mol) to achieve high levels of fidelity.  However, this dogma is based upon 
differences in the melting temperatures of duplexed DNA containing either correctly or 
incorrectly base paired termini [12].  These studies are at best an approximation of base 
pair stability as the cooperative nature of DNA melting could mask stability differences 
of a single base pair in the duplex.  The melting profiles of DNA containing mismatches 
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at the center of their duplex as opposed to at their terminus display a much larger 
∆∆G˚melting (2.0-4.8 kcal/mol) between correct and incorrect base pairs, showcasing the 
problems associated with using melting temperatures to estimate base pair stability [15].  
It is likely that the mismatch is causing a distortion to the structure of the duplexed DNA.  
This distortion is spread to the nearest neighbors, of which a terminal mismatch would 
only have one, and from there propagates to more distant neighbors.  Therefore, the 
closer to the center of the duplex a mismatch is placed the more destabilizing effect it can 
have and the closer a mismatch is placed to a terminus the more the destabilizing effect 
can be masked by limiting the number of neighbors the destabilization is propagated to.    
 
We have directly quantified ∆Gºincorporation by measuring Keq of the DNAn ↔ DNAn+1 
reaction.  The ∆∆Gºincorporation between correct and incorrect base pair formation varied 
from 3.52±0.80 to 6.98±0.17 kcal/mol with an average ∆∆Gºincorporation of 5.2±1.34 
kcal/mol, enough energy to account for error rates as accurate as 10-5.  This is in stark 
contrast to the current dogma and indicates that the energetics of base pairing can account 
for large levels of polymerase fidelity with little to no amplification of ∆∆Gºincorporation by 
the polymerase.   
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Regulation of the influenza polymerase’s switch between replication and 
transcription: 
Influenza presents a serious health threat.  Each year it is responsible for over 200,000 
hospitalizations and 36,000 deaths in the United States alone.  Pandemic years can bring 
the world wide death toll into the millions.  The worst pandemic to date, the Spanish Flu 
of 1918, was responsible for the death of over 50 million individuals [16].  Once a 
pandemic hits the only line of defense against mass casualties is antiviral therapeutics.  
Increasing resistance to current anti-influenza therapeutics has lead to the search for more 
drug targets.  To date there are no therapeutics targeting the influenza polymerase.  In the 
case of other viral diseases, the viral polymerases have provided excellent drug targets 
(i.e., Herpes and HIV) (Figure 2).  Thus, the influenza polymerase would likely prove a 
critical therapeutic target as well.    
 
The influenza RNA-dependent RNA polymerase (RdRp) is a heterotrimeric complex 
responsible for both the replication of influenza’s RNA genome and transcription of viral 
                Acyclovir                                                                            AZT 
Figure 2.  The nucleoside analogs Acyclovir and AZT are prodrugs 
respectively used to combat Herpes and HIV.  Both act as “chain terminators,” 
once the viral polymerase incorporates the nucleotide analog it is unable to 
elongate past the analog. 
 7
mRNA.  Several catalytic activities are associated with the three subunits of the 
polymerase and are required for proper replicational and transcriptional function.  
Endonuclease activities have been linked to the polymerase’s PA subunit [17, 18].  The 
polymerase active site most likely resides in the PB1 subunit while PB2 contains the 7-
methylguanosine 5’ cap binding site [19-23].  Nucleoproteins (NP) protect and package 
viral genomic segments and are required for replication in vivo, but not in vitro (Figure 3) 
[24].   
 
Replication of influenza’s negative sense, segmented, RNA genome begins with vRNA 
as a template to produce a complementary cRNA segment.  The RdRp then uses the 
cRNA as a template for the production of a new vRNA segment 
(vRNA→cRNA→vRNA) [25-27].  Prior to both replication events (vRNA→cRNA and 
cRNA→vRNA) both the 3’ and 5’ end of the template must bind to the RdRp [28].  The 
influenza RdRp also uses vRNA as a template for the production of viral mRNA.  
Influenza’s mRNA requires a 7-methylguanosise 5’ cap and a polyadenylated 3’ tail to 
Figure 3. The influenza ribonucleoprotein complex consists of a genomic RNA 
segment that is both packaged by nucleoproteins and bound to the PB1 subunit of the 
heterotrimeric polymerase by the segment’s 3’ and 5’ end. 
PA 
PB1 
NP 
PB2 
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survive inside the eukaryotic host cell.  As influenza is not capable of producing its own 
5’ cap the RdRp will bind the cap of a host mRNA transcript and use an internal 
endonuclease to cleave a capped RNA segment 9-17 nucleotides from the 5’ end of the 
host transcript [23, 29].  The influenza RdRp will then begin synthesizing its own mRNA 
directly onto the 3’ end of this stolen capped segment.  The result is that every influenza 
mRNA transcript contains a short segment (9-17 nucleotides) of host mRNA at its 5’ end.  
As the RdRp reaches the 5’ end of the vRNA template it encounters an oligo-U tract, 
which it reiteratively stutters over to transcribe a 3’ polyadenylated tail [30-32] (Figure 
4).  In the case of transcription (vRNA→mRNA) binding of the 5’ end of vRNA alone 
 
 
m7G 
5’ cap 
   
 
Host mRNA 
              mRNA Transcription 
Cap Cleavage 
   
        
 
        AAA(n) 3’ 
5’ Cap Primed  
Transcription 
vRNA Template 
 
 
m7G  
5’ Cap Nascent viral mRNA 3’ 
3’ 5’ 
     vRNA Template 
                  
        cRNA 
          
new vRNA 
       
   5’ 
        
     5’ 
  5’ 
3’ 
       3’ 
  3’ 
 
 
m7G  
5’ Cap 
Viral mRNA 
              Replication 
Figure 4. Scheme of influenza replication and transcription. Upper Panel: RdRp uses 
vRNA and cRNA alternatively as templates to produce nascent vRNA.  Lower 
Panel: RdRp cleaves a capped segment from a host transcript then polymerizes its 
own mRNA directly onto the 3’ end of the stolen segment. 
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can stimulate cap binding while binding of the vRNA 3’ end is required for endonuclease 
activity as well as initiation of transcription [33, 34].          
 
Given that the RdRp is capable of both replication and transcription from the vRNA 
template there are three possible models for the order of its replicational and 
transcriptional activities throughout infection. Model 1: the viral polymerase 
stochastically produces equal amounts of replicational and transcriptional products 
throughout the course of the entire infection.  Model 2: the polymerase replicates the viral 
genome at the beginning of infection and switches to transcription at later stage.  Model 
3: the RdRp transcribes viral mRNA at the early stages of infection then switches to 
replication of the influenza genome.  Model 3 would appear to be the most advantageous 
for the virus, early transcription of mRNA would lead to rapid translation of viral 
proteins which in turn could protect the virus from the host immune system and then be 
used at a later stage to replicate the viral genome.  Indeed the first RdRp products 
detected in influenza infected cells are viral mRNA.  At later stages of infection a 
decrease in the production of viral mRNA coincides with an increase in cRNA and vRNA 
production [35-37].  This suggests that the viral polymerase begins in a primarily 
transcriptional mode and switches towards replication throughout the infection cycle.  
How this switch is controlled remains largely unanswered.     
 
A current hypothesis regarding the switch deals with the stabilization of RdRp products.  
In the stabilization model the polymerase is stochastically producing viral mRNA as well 
as cRNA and vRNA products.  During the early stages of infection the 7-
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methylguanasine 5’ cap and 3’ polyadenylated tail of influenza’s mRNA protect it from 
host nucleases, while there is not yet enough newly translated RdRp and NP to protect the 
nascent vRNA and cRNA from degradation.  At later stages of infection enough RdRp 
and NP have been translated to stabilize the vRNA and cRNA [38, 39].  This model 
accounts for the early accumulation of viral mRNA and the delayed accumulation of 
replicational products.  There is also evidence that viral factors, such as the influenza 
NS2 protein, can effect a switch between transcription and replication [40].    
 
Using an in vitro assay that simultaneously detects replicational and transcriptional 
products we provide evidence that one host and two viral factors initiate a switch between 
the influenza polymerase’s transcriptional and replicational functions.  We propose a 
model for switching which does not exclude the stabilization model, but in fact can be 
used in conjunction with it.  During the early stages of infection influenza RdRp has 
access to large quantities of host mRNA transcripts, and loses this access at later stages of 
infection [41-43]. Our data indicate that host mRNA transcripts containing a 7-
methylguanosine 5’ cap are likely responsible for starting the polymerase off in a 
primarily transcriptional mode.  At later stages of infection viral proteins including RdRp 
and NP accumulate.  We found that high concentrations of RdRp itself initiate a switch 
from transcription of mRNA to replication of cRNA and vRNA, which are stabilized by 
the newly translated RdRp and NP.  Our assays demonstrate that one of these 
replicational products, vRNA, is also able to switch the influenza polymerase towards 
replication, likely via binding of it 5’ end.  This model accounts for the early buildup of 
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viral mRNA products and a latter accumulation of replicational products that is observed 
during influenza infection.   
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Footnotes 
1
 Abbreviations used: Complementary RNA (cRNA), Viral Ribonucleoprotein packaging cRNA 
(cRNP), Dithiothreitol (DTT), Ethylenediaminetetraacetic acid (EDTA), 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES), Phenylmethanesulfonylfluoride (PMSF), RNA-dependent 
RNA polymerase (RdRp), Tandem Affinity Purification (TAP), Viral RNA (vRNA), Viral 
Ribonucleoprotein packaging vRNA (vRNP) 
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Abstract 
The influenza RNA-dependent RNA polymerase (RdRp) both replicates the flu’s RNA 
genome and transcribes its mRNA.  Replication occurs de novo; however, initiation of 
transcription requires a 7-methylguanosine 5’ capped primer that is “snatched” from host mRNA 
via endonuclease and cap binding functions of the influenza polymerase.  A key question is how 
the virus regulates the relative amounts of transcription and replication. We found that the 
concentration of a capped cellular mRNA, the concentration of the 5’-end of the viral RNA, and 
the concentration of RdRp all regulate the relative amounts of replication versus transcription.  
The host mRNA, from which the RdRp snatches its capped primer, acts to upregulate transcription 
and repress replication.  Elevated concentrations of the RdRp itself switch the influenza 
polymerase towards replication, likely through an oligomerization of the polymerase.  The 5’-end 
of the vRNA template both activates replication and inhibits transcription of the vRNA template, 
thereby indicating that RdRp contains an allosteric binding site for the 5’ end of the vRNA 
template.  These data provides insights into the regulation of RdRp throughout the viral life cycle 
and how it synthesizes the appropriate amounts of viral mRNA and replication products (vRNA 
and cRNA).     
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Introduction 
Influenza encodes a heterotrimeric RNA-dependent RNA polymerase complex (RdRp 1) that both 
replicates the influenza’s RNA genome as well as transcribes its mRNA.  The heterotrimeric 
complex consists of three subunits: PA, PB1, and PB2.  The PA subunit is likely responsible for 
the endonuclease activities of the polymerase [1,2].  The polymerase active site most likely resides 
in the PB1 subunit while PB2 contains the 7-methylguanosine 5’ cap binding site [3-7].   
 
Replication occurs de novo and begins with vRNA acting as a template to produce a cRNA 
intermediate which in turn becomes the template for producing more vRNA strands (vRNA → 
cRNA → vRNA) [8-10].  In its transcriptional capacity the polymerase also uses vRNA as a 
template (vRNA → mRNA).  However, the influenza virus cannot produce its own 7-
methylguanosine 5’ cap and, therefore, requires a capped primer for transcription.  To solve this 
problem, the influenza polymerase contains cap binding and endonuclease functions that enable it 
to cleave capped primers from host mRNA [7,11].  Cleavage occurs 9-17 nucleotides from the 5’ 
end of the host mRNA, typically after a purine.  Following cleavage, the polymerase begins 
synthesizing its own mRNA onto the 3’ end of the stolen, capped primer.  When the polymerase 
encounters an oligo-U tract near the 5’ end of the vRNA template it reiteratively stutters over the 
sequence, thereby producing a mRNA containing a 3’ polyadenylated tail [12-14].  The 
polymerase, therefore, has two quite distinct functions and presumably must regulate the 
frequency with which it generates mRNA versus replication products. However, the mechanism 
by which the polymerase switches between these activities has yet to be fully determined. 
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Previous studies have shown that at early stages of infection viral mRNA can be readily detected 
while very little if any cRNA can be detected [15-18].  At later stages of infection both cRNA and 
mRNA are observed, along with increasing amounts of vRNA.  This suggests that at early stages 
of infection the polymerase acts in primarily a transcriptional mode and that at later stages it 
switches to a replicational mode.  One switching model suggests that early in infection both 
mRNA and cRNA are produced, but the unprotected cRNA is exposed to host nucleases and is 
degraded while the capped and polyadenylated mRNA is protected [19,20].  At later stages of 
infection substantial amounts of nascent RdRp and nucleoprotein (NP) have been produced, and 
these stabilize and protect the cRNA from degradation.  It has also been suggested that the 
influenza’s non-structural protein 2 (NS2) plays a more direct role in switching the polymerase 
from transcription to replication, likely via an interaction with the polymerase complex [18].   
 
In this study we show that the concentration of RdRp, viral template, and host cap source can 
regulate the polymerase’s switch between transcription and replication.  In vitro RdRp 
reconstitution assays indicate that high concentrations of either RdRp or viral template initiate a 
switch from transcription to replication and that high concentrations of cap source switch the 
polymerase from replication to transcription.   
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Experimental Methods 
Plasmids:  pcDNA constructs coding for the PA, PB1, and PB2 subunits were used to transfect 
293T cells (described below.)  The PB2 construct contains a C-terminal TAP tag.  The pcDNA-
PA, pcDNA-PB1, and pcDNA-PB2tap plasmids were a generous gift of Dr. George G. Brownlee, 
Sir William Dunn School of Pathology, University of Oxford.   
RNA:  The vRNA 3’ end segment 5’-GGCCUGCUUUUGCU-3’, vRNA 5’ end segment 5’-
AGUAGAAACAAGGCC-3’, cRNA 3’ end segment 5’- GGCCUUGUUUCUACU - 3’, cRNA 5’ 
end segment 5’- AGCAAAAGCAGGCC - 3’, and xRNA segment 5’- AGGGGGUUCCCC - 3’ 
were purchased from Dharmacon.  Lyophilized rabbit globin mRNA was purchased from Sigma.   
Preparation and partial purification of influenza polymerase:  The RdRp was expressed and 
purified essentially as previously described [21, 22]. The pcDNA-PA, pcDNA-PB1, and pcDNA-
PB2-TAP plasmids were transfected into 293T cells using Lipofectamine 2000 (Invitrogen) 
transfection reagent to prepare WT RdRp, while only pcDNA-PB1 and pcDNA-PB2-TAP were 
transfected to prepare –PA RdRp.  48 hours post transfection the cells were harvested and lysed in 
lysis buffer (50mM HEPES pH 8.0, 25% glycerol, 0.5% NP40, 40mM NaCl, and 10mM 2-
mercaptoethanol) containing Complete-Mini, EDTA-Free protease inhibitor cocktail tablet 
(Roche).  Following centrifugation of the lysate the cell supernatant was added to IgG Sepharose 6 
Fast Flow beads (GE Healthcare) in binding buffer (10 mM HEPES pH 8.0, 10% glycerol, 0.1% 
NP40, 150 mM NaCl, and 50 µM PMSF) and the polymerase was partially purified by taking 
advantage of the Protein-A binding site genetically encoded in the TAP tag of the PB2 construct.  
The polymerase was eluted in elution buffer (10 mM HEPES pH 8.0, 10% glycerol, 0.1% NP40, 
150 mM NaCl, 50 µM PMSF, and 1mM DTT) from the beads with tobacco etch virus protease 
that takes advantage of a TEV cleavage site separating the Protein-A tag from the PB2 subunit 
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[21, 22].  The partially purified polymerase was analyzed via silver stain and Bradford assay to 
assess purity and concentration and stored at -20ºC in 45% glycerol.   
Transcription/ vRNA → cRNA replication assay:  Assays (6 µl) were performed essentially as 
previously described [8] and contained 16 nM partially purified polymerase, 200 µM DTT, 5mM 
MgCl2, 1 unit/µl RNase OUT (Invitrogen), 1mM ATP, 500 µM CTP, 500 µM UTP, 1 µM GTP, 
0.15 µM [α-32P]GTP (3000 Ci/mmol), 1.8 ng/µl (14nM) globin mRNA (Invitrogen), 650 nM 
vRNA 3’ end segment, and 650 nM vRNA 5’ end segment unless stated otherwise.  They were 
incubated at 30O C and quenched with gel loading buffer (90% formamide). Products were 
analyzed on a 30% polyacrylamide gel and quantitated on a Typhoon Phosphorimager using 
Image Quant software (Molecular Dynamics). 
cRNA → vRNA replication assay:  Assays (6 µl)  were performed essentially as previously 
described [21] and contained 16 nM partially purified polymerase, 200 µM DTT, 5mM MgCl2, 1 
unit/µl RNase OUT (Invitrogen), 500 µM ATP, 500 µM GTP, 500 µM UTP, 1 µM CTP, 0.15 µM 
[α-32P]CTP (3000 Ci/mmol), 650 nM  cRNA 3’ end segment, and 650 nM cRNA 5’ end segment 
unless stated otherwise. They were incubated at 30O C and quenched with gel loading buffer (90% 
formamide). Products were analyzed on a 30% polyacrylamide gel and quantitated on a Typhoon 
Phosphorimager using Image Quant software. 
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Results 
The influenza polymerase is tasked with both replication of the flu’s RNA genome and 
transcription of its mRNA; however the question of how the polymerase regulates these two 
functions remains largely unanswered.  Thus, we examined the effects of the concentrations of cap 
source, polymerase, and vRNA on replication and transcription using a transcription/replication 
assay that could simultaneously detect both transcription (vRNA → mRNA) and replication 
(vRNA → cRNA) from a vRNA template and a cRNA → vRNA replication assay.  The assays 
contained the 3 subunit polymerase produced from recombinant PA, PB1, and PB2 subunits, 14 
and 15 nucleotide-long RNA segments that served as the conserved 3’ and 5’ ends of the vRNA or 
cRNA template, [α-32P]NTPs to body label the various products, and if present, rabbit globin 
mRNA was used as a 7-methylguanasine-5’-cap source. Importantly, the transcription and 
replication products can be easily differentiated due to their very different lengths. Replication 
products will be around 14 or 15 nucleotides long, the length of the 3’ end of the supplied vRNA 
or cRNA respectively, and their synthesis requires both the 3’end and the 5’end of their respective 
template and all three RdRp subunits (Figures 1a and 1b).  Omitting CTP, the third nucleotide 
required for replication, results in production of a dinucleotide (pppApG) but no longer replication 
products (data not shown). Transcription products will be around 28 nucleotides, the length of the 
3’ end of the vRNA plus the capped primer snatched from the globin mRNA, and their synthesis 
requires both ends of the vRNA template, globin mRNA, and all three RdRp subunits (Figures 1a 
and 1b).  
 
High concentrations of mRNA cap source cause a switch from replication to transcription.  We 
initially examined how varying the concentration of the mRNA cap source affected the ratio of  
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transcription/replication by titrating globin mRNA into transcription/replication assays, with the 
globin mRNA acting as the influenza polymerase’s 7-methylguanosine 5’ cap source.  As the 
concentration of globin mRNA increased from 0 to 3 ng/ul, the ratio of transcription/replication 
rose as well (Figure 2a).  The increase in the ratio of transcription/replication was due both to an 
increase in transcription and a decrease in replication, indicating that at higher concentrations of 
cellular mRNA the polymerase will favor transcription over replication (Figure 2b).   
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Figure 1.  Identification of replicational and transcriptional products.  Panel a: 
Transcription and vRNA→cRNA replication activity was assayed in the presence of 
650 nM 3’vRNA end (lanes 1,3,4,and 5), 650 nM 5’vRNA end (lanes 2-5), and 1.8 
ng/ul globin mRNA (lanes 4 and 5) using partially purified WT RdRp containing the 
PA, PB1, and PB2-TAP subunits (lanes 1-4) or partially purified –PA RdRp 
containing only the PB1 and PB2-TAP subunits (lane 5) as described in Experimental 
Procedures.  Panel b: cRNA→vRNA replication activity was assayed in the presence 
of 650 nM 3’cRNA end (lanes 1,3,4,and 5), 650 nM 5’cRNA end (lanes 2-5), and 1.8 
ng/ul globin mRNA (lanes 4 and 5) using partially purified WT RdRp containing the 
PA, PB1, and PB2-TAP subunits (lanes 1-4) or partially purified –PA RdRp 
containing only the PB1 and PB2-TAP subunits (lane 5) as described in Experimental 
Procedures.  The positions of 14 nt, 20 nt, and 49 nt size markers are shown on the 
right while transcriptional products (T), replicational products (R), and unknown 
products (*) are indicated on the left. 
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The decrease in vRNA → cRNA replication at higher cap source concentrations raised the 
possibility that high concentrations of the cap source would also inhibit cRNA → vRNA 
replication, thereby inhibiting the entire vRNA → cRNA → vRNA replication scheme.  To survey 
the later half of the replicational pathway we titrated globin mRNA into a cRNA → vRNA 
replication assay. Again, increasing concentrations of globin mRNA inhibited replication (Figure 
2c).  Thus, higher mRNA concentrations favor transcription over replication by inhibiting both 
halves of the replication cycle, vRNA → cRNA and cRNA → vRNA, and by increasing 
transcription.  
 
The 5’ end of the vRNA template helps regulate the ratio of transcription to replication.  We 
examined the effect of varying the vRNA concentration on transcription and replication. The 
vRNA serves as template for both replication and transcription, and its concentration varies greatly 
during the infection cycle – low upon initial infection, and high at later stages.  Increasing the 
concentration of vRNA in an assay that supports both transcription and replication resulted in 
decreased mRNA production along with increased vRNA to cRNA replication.  Thus, the 
concentration of vRNA can alter the ratio of transcription/replication such that higher 
concentrations of vRNA cause a switch from transcription to replication (Figure 3a).   
 
Both the 3’ and 5’ ends of the vRNA template must bind to influenza polymerase before either 
transcription or replication can begin [23-25]. This raises the question of whether the 3’ end, 5’ 
end, or both ends of vRNA are required to regulate the ratio of transcription to replication.  The 
transcription/replication reconstitution assay uses separate RNA segments to mimic the ends of the 
vRNA (a 14 nucleotide segment to mimic the 3’-end and a 15 nucleotide segment to mimic the 5’  
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Figure 2. The effects of cap source concentration on transcription and replication.  
Cap source was titrated into transcription/replication assays using vRNA (Panels a and 
b) or cRNA (Panel c) as the template; assays were performed as described under 
Experimental Procedures. Panel a: The effects on the ratio of transcription to 
replication.  Panel b: The amounts of cRNA () or transcriptional products () 
produced (pmol min-1 x 107).  Panel c: Effects of cap source on cRNA → vRNA 
replication on amounts of vRNA products produced (pmol min-1 x 107).  The figures 
shown are single representatives of two separate experiments. 
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Figure 3. The effect of vRNA on transcription and vRNA → cRNA replication.  The 
vRNA 3’ and 5’ ends (Panel a), vRNA 3’ end (Panel b), vRNA 5’ end (Panel c), and a 
control, xRNA, (Panel d) were titrated into transcription/replication assays that were 
performed as described under Experimental Procedures.  The panels on the left depict 
the ratio of transcription to replication upon addition of the noted RNA.  The panels on 
the right show the absolute amounts of cRNA () and transcriptional products () 
produced (pmol min-1 x 107).  The figures shown are single representatives of two 
separate experiments.   
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end). Thus, we can hold the concentration of one end constant while independently varying the 
concentration of the other.  The concentration of the 3’ end of vRNA had no effect on the ratio of 
transcription/replication, whereas increasing the concentration of the 5’ end of vRNA decreased 
the ratio of transcription/replication (Figure 3b and 3c). These data establish the 5’ end of vRNA 
as a regulator of the switch from transcription to replication. 
 
Control RNA has no effect on the switch between replication and transcription. To provide further 
evidence that the effects of varying the concentrations of vRNA and capped mRNA did not result 
from non-specific effects, we examined xRNA, a short oligoribonucleotide unrelated to influenza 
(Table 1).  As expected, control experiments showed that the influenza polymerase could not 
replicate or transcribe the xRNA (data not shown).  Titrating xRNA into assays showed that 
xRNA did not affect transcription of vRNA, vRNA → cRNA replication (Figure 3d), or cRNA→ 
vRNA replication (data not shown).   These data indicate that the effects of vRNA template and 
mRNA cap source result from specific sequence and/or chemical features of the 5’ end of the 
vRNA and cap source. 
 
vRNA has little effect on cRNA to vRNA replication.  We next examined the effect of vRNA 
concentration on the cRNA → vRNA replication reaction. In contrast to the effects of increased 
vRNA concentration on the vRNA → cRNA replication reaction, increasing the concentration of 
the 3’ end, 5’ end, or both ends of the vRNA template had little effect on the rate of cRNA → 
vRNA replication until the concentrations of vRNA were equal to or greater than the concentration 
of cRNA (Figure 4a). At this point replication was strongly inhibited, most likely the result of the 
3’ end of the vRNA template hybridizing to the complementary 5’ end of the cRNA template  
 28
 
 
 
 
 
 
 
 
 
 
 
 
 
and/or the 5’ end of the vRNA template hybridizing with the complementary 3’ end of the cRNA 
template (Table 1). Presumably, once the vRNA had annealed with its cRNA counterpart, the 
cRNA was no longer available for use by the polymerase as a template for replication.  We tested 
this hypothesis by repeating these experiments with one half the initial concentration of cRNA 
template. The concentration of vRNA needed to give strong inhibition also decreased by one half, 
consistent with strong inhibition resulting from hybridization of vRNA and cRNA (data not 
shown).  These data suggest that the concentration of vRNA template has little direct effect on the 
replication of cRNA to vRNA.  
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Figure 4. The effects of vRNA on cRNA → vRNA replication and cRNA on the ratio 
of transcription/replication.  Panel a: The 3’end (), 5’ end (), and both 3’ and 5’ 
ends () of vRNA were titrated into cRNA → vRNA replication assays.  The graph 
indicates the amount of vRNA produced (pmol min-1 x 107).  Panel b: The 3’ end (), 
5’ end (), and both 3’ and 5’ ends () of cRNA were titrated into 
replication/transcription assays using a vRNA template.  The graph depicts the ratio of 
transcription to replication.  Assays were performed as described under Experimental 
Procedures.  The figures shown are single representatives of two separate experiments. 
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The cRNA template does not affect the ratio of transcription/replication.  To determine if the 
concentration of cRNA affects the relative amounts of transcription and replication on a vRNA 
template, we titrated cRNA into transcription/replication assays.  The concentration of the 3’end, 
5’end, or both cRNA ends had little effect on the ratio of transcription/replication until the 
concentration of cRNA was equal to or greater than the concentration of vRNA, at which point 
both replication and transcription were completely inhibited (Figure 4b).  This strong inhibition at 
equimolar concentrations of vRNA and cRNA most likely resulted from hybridization of the 
vRNA ends with the cRNA ends due to their complementarity, as described above.  Additionally, 
these data suggest that the concentration of the cRNA template plays no role in controlling the 
switch between transcription and replication.     
 
The polymerase can switch between replication and transcription.  To determine if enzyme that 
has engaged in replication can switch to transcription, we incubated polymerase with vRNA 
template and no cap source in a transcription/replication assay, thereby only allowing the 
polymerase to operate in the replication mode.  After 10 minutes, the reaction was split into 3 
aliquots that contained different globin mRNA concentration (0.9 ng/ul to 5.4 ng/ul), and the 
amount of transcription and replication products were determined over the course of an additional 
75 minutes.   The aliquots containing higher concentrations of globin mRNA had elevated ratios 
of transcription/replication compared to the aliquots containing lower globin mRNA 
concentrations (Figure 5a), due both to increased amounts of transcription as well as decreased 
amounts of replication (data not shown). Thus, RdRp can switch from a purely replicational mode 
to transcription and higher concentrations of a cap source result in more extensive switching to the 
transcriptional mode.  
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vRNA can switch polymerase from transcription to replication.  To determine if polymerase that 
has already committed to transcription can be switched to a replicative mode we incubated vRNA 
and globin mRNA with polymerase for 10 minutes, conditions where the polymerase is largely 
engaged in transcription.  After 10 minutes the reaction was split into 4 aliquots with varying final 
concentrations of vRNA (650 nM to 5000 nM).  The aliquots containing higher concentrations of 
vRNA had decreased ratios of transcription/replication (Figure 5b), due both to increased rates of 
replication and decreased rates of transcription (data not shown). Thus, increasing the 
concentration of vRNA can switch polymerase that is involved in transcription into the replication 
mode.    
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Figure 5.  Switching RdRp between transcription and replication.  Panel a: A vRNA 
→ cRNA replication assay was incubated for 10 minutes before being split into three 
aliquots and globin mRNA added to differing final concentrations: 0.9 ng/ul () 1.8 
ng/ul () and 5.4 ng/ul (). The assays were allowed to incubate for another 75 
minutes and products quantified.  Panel b: A transcription/replication assay with an 
initial concentration of 650 nM vRNA was allowed to incubate for 10 minutes before 
being split into four aliquots and each with differing amounts of vRNA added to give 
final concentrations of: 650 nM (), 1500 nM (), 2500 nM (), and 5000 nM (). 
The assays were allowed to incubate for an additional 75 minutes and products 
quantified.  The graphs depict the ratio of transcription to replication.  Assays were 
performed as described under Experimental Procedures.  The figures shown are single 
representatives of two separate experiments. 
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Increased polymerase concentration results in a switch from transcription to replication.  Finally, 
we examined how varying the concentration of influenza polymerase influenced the ratio of 
transcription/replication.  This was of interest since upon initial infection, the concentration of the 
polymerase will be very low while at later stages the concentration will be much higher. We 
titrated influenza polymerase into transcription/replication assays and found that as the 
concentration of polymerase increases, the amount of replication products increases 
proportionally.  In contrast, the production of transcription products increases only slightly, 
resulting in a decrease in the ratio of transcription/replication at the higher polymerase 
concentrations as compared to the lower concentrations (Figure 6a and 6b).  This indicates that as 
the concentration of the polymerase increases, the enzyme synthesizes more replication products 
compared to transcription products.  To ensure that the switch to replication was not due to a 
decline of globin mRNA or some other substrate over the course of the experiment we examined 
the formation of replicational products and transcriptional products over the course of 90 minutes 
at 43 nM RdRp (Figure 6c). The amounts of both replicational products and transcriptional 
products increased linearly throughout the entire 90 min reaction, indicating that even at the 
highest concentrations of RdRp the amounts of substrates do not become limiting.   
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Figure 6.  Titration of RdRp into a transcription/replication assay.  RdRp was titrated 
into a transcription/replication assay that was performed as described under 
Experimental Procedures.  Panel a: The effect of RdRp concentration on the ratio of 
transcription to replication.  Panel b: The effect of RdRp concentration on the amounts 
of cRNA () or transcriptional products () produced (pmol min-1 x 105).  Panel c: A 
time course of a transcription/replication assay performed at 43 nM RdRp.  Products 
are the amounts of cRNA () or transcriptional products () produced (pmol min-1 x 
104).  The figures shown are single representatives of two separate experiments.  
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Discussion  
The influenza polymerase is responsible for both the replication of influenza’s RNA 
genome and transcription of its mRNA.  We found that the concentrations of cap source, 
vRNA, and influenza polymerase all play a role in the regulation of replication and 
transcription. We have also shown that populations of polymerase that are replicating 
RNA can be switched to transcription by increasing the concentration of cap source; 
similarly, polymerase that is transcribing RNA can be switched to replication by 
increasing the concentrations of vRNA.  These data suggest that the influenza polymerase 
switches between replication and transcription in a highly controlled manner and 
responds to multiple effectors.    
 
High concentrations of cap source could shut down the entire replication pathway since 
both vRNA → cRNA as well as cRNA → vRNA replication were inhibited while 
transcription was stimulated in response to increasing cap source concentrations.  While 
it is possible that there is an allosteric site for cap source separate from the substrate 
binding site, this is not required to account for the data. Rather, RdRp may contain a 
single binding site for cap source. Once the polymerase binds a vRNA template there is a 
simple competition for the initiation of transcription via cap snatching versus the 
initiation of replication via binding of the 2 NTPs needed to initiate cRNA synthesis.  For 
example, if the two NTPs required to initiate vRNA replication bind prior to the capped 
cellular RNA, the RdRp replicates the vRNA. However, if a capped cellular mRNA binds 
the polymerase prior to the two NTPs, this may direct the polymerase to initiate 
transcription by cleaving the capped mRNA and polymerizing NTPs onto the primer. 
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Alternatively, commitment to transcription may require both binding of the capped 
mRNA followed by cap snatching.  
 
High concentrations of vRNA, specifically the 5’ end of the vRNA, cause RdRp to switch 
towards a replicational mode. We propose that since the influenza polymerase must 
already be bound to a vRNA template for either vRNA → cRNA replication or 
transcription to occur, RdRp contains an additional binding site for vRNA that is distinct 
from the substrate binding site.  The 3’ vRNA end, the 3’ cRNA end, the 5’ cRNA end, 
nor xRNA could induce the RdRp to switch towards replication, indicating that this site 
has sequence specificity for the 5’ terminus of the vRNA template.  The binding of the 5’ 
end of vRNA to an allosteric site might induce a conformational change in the 
polymerase that inhibits the binding of cap source, which would lock the polymerase in a 
replicational mode for as long as the 5’ end of vRNA is bound.  Alternatively, the 5’ end 
of vRNA might bind to the RdRp cap binding site and directly prevent the polymerase 
from binding the cap source required for transcription.   
 
Recently, Perez et al reported the existence of influenza derived small viral RNAs 
(svRNA) with sequences corresponding to the 5’ ends of the vRNA segments.  Infected 
cells will contain two sources of vRNA 5’ ends – the vRNA itself and the svRNA.  
Introduction of an antisense locked nucleic acid complimentary to the svRNA into 
influenza-infected cells caused a dysregulation of mRNA, cRNA, and vRNA synthesis 
[26], consistent with the 5’ end of the vRNA template playing an important role in 
regulating the influenza polymerase.  Thus, these svRNA may be the actual regulator of 
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the switch from transcription to replication. (Note: In these whole cell studies, the 
antisense locked nucleic acid will have bound to both the vRNA segments as well as to 
the svRNA, hence it is not strictly possible to determine if the effects of the antisense 
nucleic acid resulted from binding to svRNA, vRNA or both svRNA and vRNA.)  
  
Increasing the RdRp concentration pushes the polymerase towards synthesizing more 
replication products relative to transcription products, suggesting that the RdRp can self 
associate into oligomers. Recently, Huet et al have observed the formation of  RdRp 
oligomers in live cells with florescence cross-correlation spectroscopy and Jorba et al 
have also detected oligomers of RdRp via gel-filtration analysis [27, 28]. Formation of 
these oligomers, therefore, likely plays a key role in regulating whether RdRp produces 
viral mRNA or replicates the viral genome. While it is likely that an oligomerization of 
the three subunit RdRp is involved in this regulation, we cannot discount the possibility 
that only one of the three polymerase subunits is responsible for the switch. 
 
As influenza begins its infection of a cell it would be advantageous for the virus to 
quickly produce the viral machinery required to fend off immune responses from the 
host, replicate its own genome, and package nascent virons.  This would require that the 
viral polymerase primarily produce mRNA early in infection.  During the later stages of 
infection, once the viral components have been produced, the virus can then focus on the 
replication of its genome and the polymerase can switch towards replication of both 
cRNA and vRNA.   
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Consistent with these ideas, previous studies have indicated that during early stages of 
infection there is an accumulation of influenza mRNA and very little cRNA or vRNA, 
implying that the influenza polymerase is in a primarily transcriptional mode during the 
beginning of infection. At latter stages of infection, the concentrations of cRNA and 
vRNA increase [15-17], suggesting that the RdRp has switched to a replicational mode.  
Importantly, the results described above accurately predict such a switch. 
 
We have found that high concentrations of cap source switch the influenza polymerase to 
a transcriptional mode.  RdRp has been shown to associate with RNA polymerase II 
when the eukaryotic polymerase’s carboxy terminal domain is hyperphosphorylated, 
which would give it access to locally high concentrations of cap source [29].   Thus, 
during the early stages of infection the RdRp would have access to these locally high 
concentrations of cap source while the concentrations of vRNA and RdRp would be low 
compared to the levels found later in infection; these conditions would result in RdRp 
primarily transcribing viral mRNA.  Vreede et al have provided evidence that influenza 
polymerase mediates the ubiquitination of RNA polymerase II, thereby leading to the 
degradation of the host polymerase via the proteasome [30, 31]. This degradation should 
significantly lower the concentration of host cap source available to RdRp, thus 
decreasing the amount of transcription and increasing the amount of replication. As the 
infection progresses, the concentrations of all viral proteins increase in response to the 
accumulation of viral mRNA, with the increase in RdRp and NP concentrations 
subsequently protecting nascent cRNA from degradation.  The newly protected cRNA 
can now be used as a template for producing more vRNA and/or svRNA. Importantly, 
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this increased vRNA concentration would result in RdRp switching into the replicational 
mode.  The svRNAs consisting of 5’-end of the vRNA segments would also likely 
contribute to this effect. While it is unknown how the concentration of svRNAs varies 
during the infection cycle, one would expect them to increase since their production is 
presumably dependent upon the presence of cRNA. Thus, the increasing levels of vRNA 
and svRNA serve as a positive feedback loop for even greater vRNA production. The 
increase in RdRp concentration during the infection cycle would also lead to self 
association of the polymerase, further enhancing the switch towards replication.   
 
Regulation of the relative amounts of transcription versus replication almost certainly 
involves processes other than those described above. Vreede et al. have proposed a 
stabilization model whereby at early stages of infection the polymerase is synthesizing 
both cRNA and mRNA. However, the product of replication, cRNA, is unprotected by 
proteins and quickly degraded by host nucleases while the mRNA’s 7-methylguanosine 
5’ cap and polyadenylated tail protect it from degradation and allow it to be exported 
from the nucleus.  At later stages of infection the mRNA will have been translated to 
generate large amounts of RdRp and nucleoproteins, both of which bind to and stabilize 
the cRNA against degradation [19, 20].  This stabilization model would also help account 
for the early accumulation of mRNA followed by a build up of cRNA (and vRNA) later 
in infection.   
 
Robb et al reported that the influenza NS2 protein plays a role in regulating the influenza 
polymerase by decreasing the ratio of transcriptional/replicational products [18].  It seems 
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that influenza NS2 and RdRp are both regulators in a negative feedback loop where 
influenza polymerase will transcribe viral mRNA which will then be used to translate 
viral proteins including NS2 and RdRp; once levels of NS2 and RdRp are high enough, 
they convert RdRp from a transcriptional mode to a replicative mode.         
 
Figure 7 summarizes the effects of varying vRNA, capped cellular mRNA and RdRp on 
the relative rates of transcription and replication.  During early stages of infection there 
are low levels of vRNA and RdRp and locally high concentrations of capped cellular 
mRNA.  The elevated cap source concentration signals an increase in the production of 
transcriptional products while inhibiting both vRNA → cRNA and cRNA → vRNA 
replication, thereby increasing the rate of transcription and, therefore, the rate at which 
viral proteins accumulate.  Later stages of infection feature the decline of the 
concentration of capped cellular mRNA and an increase in the levels of both vRNA and 
RdRp, both of which signal a decrease in the rate of transcription and an increase in 
replication. In combination with other reported regulatory mechanisms described above, 
it is clear that influenza has developed a remarkably complex regulatory network for 
ensuring the appropriate levels of viral mRNA needed for protein production and vRNA 
that will both serve as a substrate and be packaged into new viral particles. Indeed, it 
would not be surprising if future studies report the existence of additional viral and host 
factors that regulate the rates and balance between transcription and replication.   
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Figure 7.  The viral ribonucleoprotein complex (vRNP) can be influenced to adopt a 
transcriptional mode by increased concentrations of cap source, whereas increased 
concentrations of vRNA and viral polymerase will effect a switch towards replication.  
Encircled plus signs indicate stimulation while T bard indicate repression.  
 
RdRp 
Cap AAA(n) 
cRNP vRNA 
mRNA 
Cap Source 
Cap Source 
vRNP 
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RNA name RNA sequence 
vRNA 3’ end 5’-GGCCUGCUUUUGCU-3’ 
vRNA 5’ end 5’-AGUAGAAACAAGGCC-3’ 
cRNA 3’ end 5’- GGCCUUGUUUCUACU - 3’ 
cRNA 5’ end 5’- AGCAAAAGCAGGCC - 3’ 
xRNA 5’- AGGGGGUUCCCC - 3’ 
 
Table 1.  Table of RNA sequences used in Transcription/Replication assays. 
 41
References 
1. Dias, A., Bouvier, D., Crepin, T., McCarthy, A. A., Hart, D. J., Baudin, F., 
Cusack, S., and Ruigrok, R. W. (2009) The cap-snatching endonuclease of 
influenza virus polymerase resides in the PA subunit, Nature 458, 914-918. 
2. Yuan, P., Bartlam, M., Lou, Z., Chen, S., Zhou, J., He, X., Lv, Z., Ge, R., Li, X., 
Deng, T., Fodor, E., Rao, Z., and Liu, Y. (2009) Crystal structure of an avian 
influenza polymerase PA(N) reveals an endonuclease active site, Nature 458, 
909-913. 
3. Guilligay, D., Tarendeau, F., Resa-Infante, P., Coloma, R., Crepin, T., Sehr, P., 
Lewis, J., Ruigrok, R. W., Ortin, J., Hart, D. J., and Cusack, S. (2008) The 
structural basis for cap binding by influenza virus polymerase subunit PB2, 
Nature structural & molecular biology 15, 500-506. 
4. Braam, J., Ulmanen, I., and Krug, R. M. (1983) Molecular-Model of a Eukaryotic 
Transcription Complex - Functions and Movements of Influenza-P Proteins 
During Capped Rna-Primed Transcription, Cell 34, 609-618. 
5. Blaas, D., Patzelt, E., and Kuechler, E. (1982) Cap-recognizing protein of 
influenza virus, Virology 116, 339-348. 
6. Blaas, D., Patzelt, E., and Kuechler, E. (1982) Identification of the cap binding 
protein of influenza virus, Nucleic acids research 10, 4803-4812. 
7. Ulmanen, I., Broni, B. A., and Krug, R. M. (1981) Role of two of the influenza 
virus core P proteins in recognizing cap 1 structures (m7GpppNm) on RNAs and 
in initiating viral RNA transcription, Proceedings of the National Academy of 
Sciences of the United States of America 78, 7355-7359. 
8. Deng, T., Vreede, F. T., and Brownlee, G. G. (2006) Different de novo initiation 
strategies are used by influenza virus RNA polymerase on its cRNA and viral 
RNA promoters during viral RNA replication, Journal of virology 80, 2337-2348. 
9. Hay, A. J., Lomniczi, B., Bellamy, A. R., and Skehel, J. J. (1977) Transcription of 
the influenza virus genome, Virology 83, 337-355. 
10. Hay, A. J., Skehel, J. J., and McCauley, J. (1982) Characterization of influenza 
virus RNA complete transcripts, Virology 116, 517-522. 
11. Plotch, S. J., Bouloy, M., Ulmanen, I., and Krug, R. M. (1981) A unique 
cap(m7GpppXm)-dependent influenza virion endonuclease cleaves capped RNAs 
to generate the primers that initiate viral RNA transcription, Cell 23, 847-858. 
12. Robertson, J. S., Schubert, M., and Lazzarini, R. A. (1981) Polyadenylation sites 
for influenza virus mRNA, Journal of virology 38, 157-163. 
13. Poon, L. L., Pritlove, D. C., Fodor, E., and Brownlee, G. G. (1999) Direct 
evidence that the poly(A) tail of influenza A virus mRNA is synthesized by 
reiterative copying of a U track in the virion RNA template, Journal of virology 
73, 3473-3476. 
14. Poon, L. L., Fodor, E., and Brownlee, G. G. (2000) Polyuridylated mRNA 
synthesized by a recombinant influenza virus is defective in nuclear export, 
Journal of virology 74, 418-427. 
15. Taylor, J. M., Illmensee, R., Litwin, S., Herring, L., Broni, B., and Krug, R. M. 
(1977) Use of specific radioactive probes to study transcription and replication of 
the influenza virus genome, Journal of virology 21, 530-540. 
 42
16. Mark, G. E., Taylor, J. M., Broni, B., and Krug, R. M. (1979) Nuclear 
accumulation of influenza viral RNA transcripts and the effects of cycloheximide, 
actinomycin D, and alpha-amanitin, Journal of virology 29, 744-752. 
17. Engelhardt, O. G., and Fodor, E. (2006) Functional association between viral and 
cellular transcription during influenza virus infection, Rev. Med. Virol. 16, 329-
345. 
18. Robb, N. C., Smith, M., Vreede, F. T., and Fodor, E. (2009) NS2/NEP protein 
regulates transcription and replication of the influenza virus RNA genome, The 
Journal of general virology 90, 1398-1407. 
19. Vreede, F. T., and Brownlee, G. G. (2007) Influenza virion-derived viral 
ribonucleoproteins synthesize both mRNA and cRNA in vitro, Journal of virology 
81, 2196-2204. 
20. Vreede, F. T., Jung, T. E., and Brownlee, G. G. (2004) Model suggesting that 
replication of influenza virus is regulated by stabilization of replicative 
intermediates, Journal of virology 78, 9568-9572. 
21. Kashiwagi, T., Leung, B. W., Deng, T., Chen, H., and Brownlee, G. G. (2009) 
The N-terminal region of the PA subunit of the RNA polymerase of influenza 
A/HongKong/156/97 (H5N1) influences promoter binding, PloS one 4, e5473. 
22. Deng, T., Sharps, J., Fodor, E., and Brownlee, G. G. (2005) In vitro assembly of 
PB2 with a PB1-PA dimer supports a new model of assembly of influenza A virus 
polymerase subunits into a functional trimeric complex, Journal of virology 79, 
8669-8674. 
23. Fodor, E., Pritlove, D. C., and Brownlee, G. G. (1994) The influenza virus 
panhandle is involved in the initiation of transcription, Journal of virology 68, 
4092-4096. 
24. Cianci, C., Tiley, L., and Krystal, M. (1995) Differential activation of the 
influenza virus polymerase via template RNA binding, Journal of virology 69, 
3995-3999. 
25. Hagen, M., Chung, T. D., Butcher, J. A., and Krystal, M. (1994) Recombinant 
influenza virus polymerase: requirement of both 5' and 3' viral ends for 
endonuclease activity, Journal of virology 68, 1509-1515. 
26. Perez, J. T., Varble, A., Sachidanandam, R., Zlatev, I., Manoharan, M., Garcia-
Sastre, A., and Tenoever, B. R. (2010) Influenza A virus-generated small RNAs 
regulate the switch from transcription to replication, Proceedings of the National 
Academy of Sciences of the United States of America 107, 11525-11530. 
27. Huet, S., Avilov, S. V., Ferbitz, L., Daigle, N., Cusack, S., and Ellenberg, J. 
(2010) Nuclear import and assembly of influenza A virus RNA polymerase 
studied in live cells by fluorescence cross-correlation spectroscopy, Journal of 
virology 84, 1254-1264. 
28. Jorba, N., Area, E., and Ortin, J. (2008) Oligomerization of the influenza virus 
polymerase complex in vivo, The Journal of general virology 89, 520-524. 
29. Engelhardt, O. G., Smith, M., and Fodor, E. (2005) Association of the influenza A 
virus RNA-dependent RNA polymerase with cellular RNA polymerase II, 
Journal of virology 79, 5812-5818. 
 43
30. Vreede, F. T., Chan, A. Y., Sharps, J., and Fodor, E. Mechanisms and functional 
implications of the degradation of host RNA polymerase II in influenza virus 
infected cells, Virology 396, 125-134. 
31. Chan, A. Y., Vreede, F. T., Smith, M., Engelhardt, O. G., and Fodor, E. (2006) 
Influenza virus inhibits RNA polymerase II elongation, Virology 351, 210-217. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 44
Chapter Three 
 
The energetics of base pairing account for a 
high level of polymerase fidelity 
 
 
 
Andrew C. Olson, Jennifer N. Patro, and Robert D. Kuchta 
 
 
 
Department of Chemistry and Biochemistry, University of Colorado, UCB 215 Boulder, 
CO 80309 
 
 
 
 
 
 
 
 
 
 
 
 
 45
Abstract 
DNA polymerases facilitate highly accurate replication of the cell’s genome making a 
mistake only once every 1,000 to 1,000,000 incorporation events.  How they obtain the 
energy to achieve this level of accuracy has eluded researchers for decades.  The 
prevailing hypothesis states that there is a small energy difference between forming 
correct and incorrect base pairs and that the polymerase is required to greatly amplify this 
difference to attain high levels of fidelity.  However, this hypothesis is based upon studies 
that approximated the differences between base pairs using the melting profiles of 
duplexed DNA.  We have directly measured the incorporation of a nucleotide to obtain 
∆Gºincorporation.  Our results indicate that there is actually a large energy difference between 
forming correct and incorrect base pairs and the average ∆∆Gºincorporation is 5.2±1.34. This 
indicates that the energetics of base pairing can account for error rates more accurate than 
10-3 with out any amplification of ∆∆Gºincorporation by the polymerase. 
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Introduction 
DNA polymerases are responsible for rapid and accurate duplication of an organism’s 
genetic material.  Polymerases must discriminate between four potential substrates: 
dATP, dCTP, dTTP, and dGTP, during accurate incorporation opposite a templating 
base.  In the absence of proofreading exonucleases, polymerases can exhibit error rates of 
10-3 to 10-6, making a mistake only once every 1,000 to 1,000,000 incorporation events 
[1].  
 
The mechanism for polymerization of a single nucleotide begins with the polymerase 
binding DNA forming a binary complex (E•DNAn).  The binary complex then binds a 
dNTP (E•DNAn•dNTP) following which a conformational change takes place 
(E*•DNAn•dNTP).  At this point the polymerase catalyzes the addition of dNMP to 
DNAn resulting in the formation of pyrophosphate (PPi) and DNAn+1 (E*•DNAn+1•PPi).  
After the chemical step the polymerase can reverse its conformational change 
(E•DNAn+1•PPi) and then release PPi (E•DNAn+1 + PPi).  Finally the polymerase can 
either bind a second dNTP and processively polymerize another nucleotide or it can 
release the DNAn+1 [2-8].  Any step following the binding of DNA can provide the 
polymerase with a chance for nucleotide discrimination.  It has been well documented 
that different polymerases use different mechanisms to achieve their accuracy; however, 
where the energy for nucleotide discrimination comes from is still largely unknown [2, 6-
9].  Here we report that the energetics of base pairing can account for high levels of 
polymerase fidelity.  
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Experimental Methods 
DNA polymerases: Human DNA polymerase β was a generous gift of Dr. Samual H. 
Wilson, Laboratory of Structural Biology, NIEHS, National Institutes of Health.  Bacillus 
stearothermophilus Large Fragment , VentR (exo-) DNA Polymerase, and Klenow 
Fragment (3’→5’ exo-) were purchased from New England BioLabs. 
Oligonucleotides: DNA oligonucleotides were purchased from Integrated DNA 
Technologies. Primer strands were gel purified, 5’-32P labeled using polynucleotide 
kinase and γ-32P ATP, and annealed to their template counterpart as previously described 
[7]. 
Determination of ∆G˚:  The Keq for the correct incorporation and misincorporation of a 
nucleotide opposite a templating base was determined using equation 1 and used to 
calculate ∆Gºincorporation using equation 2.  A radio labeled primer annealed to a template 
strand was incubated in the presence of the desired dNTP (1um- 4mM) to be incorporated 
as well as pyrophosphate (PPi) (2mM-4mM), to provide an observable reverse reaction.  
An exonuclease deficient polymerase (5nM) was used as a catalyst with the primer-
template (100nM) in Tris-HCl pH 7.5 (50 mM) and MgCl2 (8mM).  Total reaction 
volume was 20 ul.  Samples were incubated at 37˚C in an air incubator to prevent reflux 
due to the formation of condensation on the sample tube lid.  Samples were taken at 
various time points and quenched with formamide.  Products were analyzed on a 20% 
polyacrylamide gel and quantitated on a Typhoon Phosphorimager using Image Quant 
software (Molecular Dynamics).  Reactions were considered to be at equilibrium when 
the ratio of DNAn / DNAn+1 did not change significantly over the course of 45 minutes.   
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Equation 1:  
 
Equation 2:         ∆G˚= -RTlnKeq where the molar gas constant R=8.314m2 kg s-2 K-1, 
 T= temperature in Kelvin, and Keq is the equilibrium constant 
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Results 
There is a large ∆∆Gºincorporation between the formation of correct and incorrect base 
pairs.  We measured ∆Gº for polymerization of a correct dNTP (∆Gºincorporation) for the 
four correct incorporation events (Figure 1a).  Reactions containing 5’-[32P]-DNAn, the 
next correct dNTP needed for elongation of DNAn into DNAn+1, and a trace amount of an 
exonuclease-deficient DNA polymerase were allowed to reach equilibrium (~45 min) 
(Figure 2b). The large excess of DNA ensured that the polymerase acted only as a 
catalyst and could not stabilize one product over the other. Attempts to avoid 
pyrophosphorolysis utilized a primer strand with a methyl-phosphonate linker between 
the DNAn and DNAn-1 positions.  The methyl-phosphonate is a poor electrophile 
compared to a standard phosphate and therefore is unable to take part in 
pyrophosphorolysis.  However, a comparison of the ∆Gºincorporation varied between 
templates using the methyl-phosphonate primer and a standard DNA primer containing a 
complete phosphate backbone (Figure 2).  Instead reactions contained sufficient dNTP 
for the nucleotide found at the n position of the primer to prevent shortening of the primer 
due to pyrophosphorolysis of DNAn (The ∆Gº and slower rates for misincorporation of a 
dNTP ensure that misincorporation of a dNTP at the n+1 position does not occur (Figure 
1b, lane 5)).  This ∆Gº variation was likely due to the methyl-phosphonate causing a 
distortion to DNA duplex’s structure.  As assurance that equilibrium of the DNAn ↔ 
DNAn+1 reaction was reached equilibrium was approached from both the DNAn position 
with Primer C/DNAa and the DNAn+1 position using Primer CT/DNAa (Table 1, far left 
column).  As expected, under the same conditions of PPi and dNTP similar ∆Gºs were 
observed for both primer  
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5’-*T  CC ATAT C AC AT         -3’ +dNTP        
3’- 
 
AGGTATAGTGTATG…-5’ 
5’-*T  CC ATAT C AC ATN      -3’ +PPi        
3’- 
 
AGGTATAGTGTATG…-5’ 
DNAn+1 DNAn 
Polymerase 
a. 
∆Gº Melting 
5’ 
5’ 
5’ 
5’ 
3’ 
3’ 3’ 
3’ 
5’ 
5’ 3’ 
3’ 
∆Gº  
Incorporation 
c. 
DNAn+1 
DNAn 
Time (min):    45         60       75        90       90        90       90 
µM dATP        2         2        2         2          0         2         0 
µM dTTP       50       50      50       50        50       50        0 
µM PPi         4000   4000   4000   4000      0         0         0   
Lane               1          2        3         4          5         6         7 b. 
Figure 1. DNAn ↔ DNAn+1 reaction.  a) incorporation of a dNTP, * indicates radio 
labeled phosphate. b) Correct incorporation of a dNTP attaining equilibrium. c) 
Comparison of ∆Gºincorporation vs ∆Gºmelting. 
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Polymerase Phosphate Bond Type ∆G˚ (kcal/mol) 
BF Methyl-Phosphonate -3.58 
BF Standard Phosphate -4.61 
KF Methyl-Phosphonate -3.75 
KF Standard Phosphate -4.64 
Figure 2. Comparison of a templates using methyl-phosphonate (depicted above) and 
standard phosphate backbones. ∆G˚ given for incorporation of C → G into Primer 
T/DNAg 
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templates (Table 1).  The ∆Gºincorporation for correct incorporation events ranged from -
4.3±0.06 to -6.2±0.10 kcal/mol and the average ∆Gºincorporation was -5.2 ± 0.40.   
 
The ∆Gº for the polymerization of an incorrect dNTP (∆Gºmisincorporation) was determined 
for all twelve possible misincorporation reactions.  These reactions differed from those 
for correct incorporation in that the reactions were performed for 16 hours to allow 
attainment of equilibrium due to the slower rate of misincorporation and contained higher 
concentrations of the incorrect dNTP.  To prevent net pyrophosphorolysis of the primer at 
the DNAn position (12mer) both the misincorporated nucleotide (i.e., the n+1 position) 
and the primer terminus (i.e., the n position) were the same.  This approach succeeds 
because the Keq for correct incorporation reaction is much higher than the Keq for 
misincorporation reaction at the DNAn+1 position. The ∆Gºmisincorporation ranged from 
1.52±0.27 to -1.57±0.79 kcal/mol and the average ∆Gºmisincorporation was 0.13 ± 1.28.  
 
The ∆∆Gºincorporation between right and wrong dNTPs varied from 3.52±0.80 to 6.98±0.17 
kcal/mol with an average ∆∆Gºincorporation of 5.2±1.34 kcal/mol, enough energy on average 
to account for error rates better than 10-3.  This contrasts with current dogma, which 
postulates that there is very little energy difference between generation of correct and 
incorrect base pairs and that the polymerase must greatly amplify this difference to 
achieve high fidelity [10, 11].  However, this model is based upon the ∆∆G˚s obtained 
from melting profiles of dsDNA with matched or mismatched primer termini (i.e., 
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∆Gºmelting).  If the mismatch is placed in the middle of the primer as opposed to the 3’-
terminus ∆Gºmelting is significantly affected, raising the question of whether melting 
profiles are the best way to determine the energetics for the generation of new base pairs 
as occurs during DNA synthesis (i.e., ∆Gºincorporation (Figure 1c)) [12].  Direct 
measurements of ∆Gºincorporation and ∆Gºmisincorporation indicate that a polymerase can 
achieve high levels of fidelity with little, if any amplification of ∆∆Gºincorporation.  These 
different conclusions presumably result from the melting of DNA being at best an 
indirect measure of the energetics of right and wrong dNTP polymerization.   
 
∆Gºincorporation is polymerase independent.  Three different exonuclease deficient 
polymerases were used to demonstrate that the enzyme acts only as a catalyst and does 
not affect ∆Gºincorporation.  Bacillus stearothermophilus Large Fragment (BF), VentR (exo-) 
DNA Polymerase (Vent exo- pol), and Klenow Fragment (3’→5’ exo-) (KF) were 
compared using Primer T/DNAt.  All three polymerases resulted in similar ∆Gºincorporation 
values for correct incorporation of dAMP opposite template T.  Only thermostable 
polymerases, BF and Vent exo- pol, could be compared for misincorporation of dTMP 
opposite template T due to the 16 hour incubation required to achieve equilibrium for a 
misincorporation event at 37ºC.  Again, both polymerases gave similar ∆Gºmisincorporation 
values (Table 1).  Together these data indicate that ∆Gºincorporation is polymerase 
independent, as one would predict for the polymerase acting as a catalyst.      
 
Large ∆∆Gºincorporation is independent of template length.  We investigated the dependence 
of the large ∆∆Gºincorporation on primer-template length.  Primer Clong/DNAa, containing a 
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27 base pair duplex region, was compared to Primer C/DNAa, containing a 12 base pair 
duplexed region.  The incorporation of dTMP and dCMP opposite template A yielded a 
∆∆Gºincorporation is 4.52±0.20 kcal/mol for the longer Primer Clong/DNAa. This is 
comparable to the ∆∆Gºincorporation of 4.49±0.29 kcal/mol for the same incorporation 
events on the shorter Primer C/DNAa (Table 1).  This indicates that the large 
∆∆Gºincorporation is independent of template length. To investigate the sequence dependence 
of ∆Gºincorporation, each of the four possible correct incorporation events was investigated 
on 3 templates with differing nearest neighbors.  While sequence of the nearest 
neighboring nucleotide was found to have an effect on the ∆Gºincorporation, a large 
∆∆Gºincorporation was always observed, regardless of sequence (Table 1).   
 
Hydrogen bonding and base stacking contribute to ∆Gºincorporation.  The importance of 
hydrogen bonding to ∆∆Gºincorporation was examined using Primer C/DNAabasic which 
contains an abasic site templating site but is otherwise identical to Primer C/DNAt  
(Table 1).  Unlike the generation of a correct base-pair, only phosphodiester bond 
formation and stacking of the base from the dNTP can drive incorporation of dNTPs onto 
this template.  Polymerization of purine dNTPs was significantly more favorable than 
polymerization of pyrimidine dNTPs (by ~1.8 kcal/mol) and consistent with previous 
studies indicating that stacking of purines is more favorable than stacking of pyrimidines 
(Table 1).  We found that the purines had a much larger ∆Gºincorporation opposite the abasic 
site than the pyrimidines, by an average of ~1.8 kcal/mol.  It is not surprising to find that 
the order of the bases in terms of thermodynamic favorability A>G>T,C is the same 
preferred order of insertion opposite abasic sites [13].  There is a large ∆Gºincorporation 
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penalty due to the absence of a templating base.  Potentially, this could result either from 
the lack of hydrogen bonds between the bases and/or altered stacking interactions of the 
template base that would occur upon incorporation of the cognate dNTP. We suspect that 
hydrogen bonding and base stacking are intrinsically linked; if a base pair is able to 
create proper hydrogen bonds it will help position the bases for optimum base stacking, 
likewise the stacking of bases could favorably align base pairs for hydrogen bonding. 
 
As the templating DNA stand passes through the active site of a polymerase it is bent 
~90˚ at the phosphate linking the templating position and one position 5’ of the 
templating base [14, 15].  We hypothesized that as a dNTP is incorporated the formation 
of a base pair with the templating base may stabilize the base stacking interactions 
between the templating base and its 5’-neighbor, providing energy for translocation of the 
polymerase along the DNA template.  If this hypothesis were accurate then placing an 
abasic site upstream of the templating position would cause a significant increase in 
∆Gºincorporation.  When the base upstream from the templating position was replaced with 
an abasic site or 4 abasic sites in a row no significant change in ∆Gºincorporation was 
observed, indicating that the polymerization of a dNTP does not stabilize the base 
stacking interaction between the templating base and the downstream base (Figure 3). 
 
In an attempt to discern the energetic contribution of phosphodiester bond formation to 
the polymerization process a 1,2 dideoxyribose triphosphate, or deoxysugar triphosphate 
(dSTP), was used as a nucleotide (Figure 4a).  The dSTP, similar to the abasic templating  
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5’- TCCATATCACA              -3’        
3’- AGGTATAGTGTCATTC -5’ 
5’- TCCATATCACA              -3’        
3’- AGGTATAGTGTC_TTC -5’ 
5’- TCCATATCACA              -3’        
3’- AGGTATAGTGTC____  -5’ 
∆Gº kcal/mol Template 
-4.6 
-4.3 
-4.5 
5’- TCCATATCACA            -3’        
3’- AGGTATAGTGTCATTC -5’ 
5’- TCCATATCACA            -3’        
3’- AGGTATAGTGTC 
5’- TCCATATCACAG           -3’        
3’- AGGTATAGTGTCATTC -5’ 
5’- TCCATATCACAG           -3’        
3’- AGGTATAGTGTC 
dGTP 
PPi 
ATTC
-5
’
 
ATTC
-5
’
 
Figure 3. Upper Panel: While in the active site the templating strand is bent at ~90˚ at 
the phosphate linking the templating position to the base on its 5’ end.  
Lower Panel: The effects of abasic sites positioned directly 5’ of the templating base 
on the ∆G˚incorporation when G→C. 
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position, is missing a base and incapable hydrogen bonding.  Due to its abasic nature it is 
also unable to obtain any energy from base stacking.  Curiously, using a variety of 
Figure 4. Deoxysugar triphosphate (dSTP) A) Structure of the dSTP.  
B) Attempted incorporation of dSTP into Primer T/DNAt using Bacillus 
stearothermophilus Large Fragment (BF), VentR (exo-) DNA Polymerase (Vent), and 
human polymerase β (Pol β). 
. 
DNAn 
DNAn-4 
µM dSTP:                 0                    500           500       500           0       500 
 
µM dTTP:                 0                      0               0          50            0         0 
 
Polymerase:             BF                   BF           Vent     Vent       Pol β   Pol β 
A) 
B) 
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polymerases, we were unable to observe incorporation of the dSTP.  In fact both BF and 
Vent exo- pol appeared to use the dSTP to drive pyrophosphorolysis, adding a small  
concentration of the dNTP of the nucleotide found at the n position of DNAn appeared to 
prevent pyrophosphorolysis, similar to PPi driven pyrophosphorolysis.  Curiously the 
repair enzyme, human polymerase β, did not use the dSTP to drive pyrophosphorolysis 
(Figure 4b).  Under the hypothesis that both Vent exo- pol and BF require the base or 
some feature within the base to recognize a dNTP as a substrate for polymerization, 
excess amounts of the bases cytosine and thymine were combined with dSTP in an 
attempt to replace its missing base and drive polymerization; no incorporation was 
observed (data not shown).  Further studies will be required to determine the exact nature 
of human polymerase β’s differential use of dSTP as compared to BF and Vent exo- pol.   
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Discussion 
We have directly measured ∆Gº for polymerization of both correct and incorrect 
nucleotides.  ∆Gºincorporation is independent of the polymerase used, as expected, the 
polymerase is a catalyst and therefore can not affect ∆Gº.  Template length has also been 
shown not to affect ∆∆Gºincorporation.  Our work indicates a large ∆∆Gºincorporation that can 
account for error rates as accurate as 10-5.   Our results stand in contrast to the current 
dogma regarding the energetics of base pairing, which postulates that there was very little 
∆Gº difference between forming correct and incorrect base pairs, requiring the 
polymerase to greatly amplify ∆∆Gº to achieve high levels of accuracy [1, 5, 10, 16].  
However, the dominant view is based upon studies of the melting profiles of duplexed 
DNA containing either correctly or incorrectly base paired termini.   
 
The melting profiles at best only provide an estimate of base pair stability.  Prior to 
phosphodiester bond formation dNTPs may use base stacking and Watson-Crick 
hydrogen bonding to transiently bind the primer/template.  It is likely that dNTPs forming 
correct base pairs with the template would have a much more favorable ∆G˚ of binding 
(∆G˚binding) than dNTPs forming mismatches.  The energy from ∆G˚binding would be 
minimized in studies using duplex melting profiles due to the preexistence of the 
phosphodiester bond which would artificially equalize the apparent binding constant of 
correct and incorrect base pairs.   Problems with using melting profiles to determine ∆Gº 
of base pairing become apparent as the mismatch is moved from the terminus of the 
duplex to the center, the apparent ∆∆Gº becomes significantly larger [11, 12].   It is likely 
that the mismatch distorts the duplex’s structure by affecting not just the nearest 
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neighbors but more distal base pairs as well.  If the mismatch is centrally located within 
the duplex its structural distortion can propagate both upstream and downstream causing 
the maximal amount of disruption.  However, when the mismatch is placed at the 
terminus of the duplex it can only affect the structure of base pairs in one direction, 
towards the center of the duplex, greatly limiting its contribution to the lack of stability of 
the duplex.  This could account for the different ∆∆Gº observations as the mismatch is 
moved from the center to the terminal position of the duplex.  Our direct measurements 
of ∆∆Gºincorporation imply that the polymerase does not have to greatly amplify 
∆∆Gºincorporation to achieve large levels of polymerase fidelity and in many cases 
∆∆Gºincorporation requires no amplification at all.    
 
While it was apparent that neighboring nucleotides affected ∆Gºincorporation, a large 
∆∆Gºincorporation was always associated with each incorporation event regardless of 
sequence.  The only condition that was found to affect ∆∆Gºincorporation was magnesium 
concentration.  At higher concentrations of MgCl2 ∆∆Gºincorporation increased, the result of 
an increase in ∆Gºincorporation and no significant change in ∆Gºmisincorporation (Table 2).  It is 
possible that the Mg2+ ions are interacting with the phosphate backbone of DNA to 
enhance the stabilization of correctly paired bases.  However, at extremely high 
concentrations of MgCl2 (>10mM) ∆∆Gºincorporation decreased, due to the decrease in 
∆Gºmisincorporation.  Future studies should investigate the affect MgCl2 concentration has on 
the fidelity of nucleotide incorporation in steady-state assays as well as continue to 
explore the effects of magnesium to ∆∆Gºincorporation.  The contributions of other metals to 
∆∆Gºincorporation warrant inquiry as well.  Additionally, work it currently underway to 
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extrapolate ∆H˚ and ∆S˚ for correct and incorrect nucleotide incorporations from Van’t 
Hoff plots.     
 
The polymerase can use the thermodynamic difference between forming correct and 
incorrect base pairs to contribute to the fidelity of a 3’-5’ exonuclease.  Following partial 
melting of the duplex terminus, the daughter strand must translocate to the exonuclease 
active site where the 3’ terminal nucleotide can be excised from the daughter strand [17].  
It is reasonable to assume that incorrect base pairs will be melted out of the template 
strand a higher percentage of the time compared to correct base pairs, giving mismatched 
nucleotides more opportunity than correctly matched nucleotides to translocate to the 
exonuclease active site to be excised, thus contributing to exonuclease fidelity.  
 
While thermodynamics provide energy for discrimination it is not practical for the 
polymerase to wait until equilibrium has been achieved.  The polymerase contains 
features of its mechanistic pathway, e.g. dNTP binding and the conformational change, 
which allow it to access this energy under non-equilibrium conditions to rapidly 
incorporate the next correct nucleotide [2, 5-8, 16, 18-20].  Different polymerases display 
fidelity at varying points along their mechanistic route, however, each polymerase has the 
opportunity to capture the energy difference between the formation of the two possible 
products, a correct base pair and an incorrect base pair, which can be used by the 
polymerase at the point of discrimination to account for high levels of fidelity (Figure 5).   
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It will be interesting to see if these same principles to apply to DNA dependent RNA 
polymerases as well as RNA dependent RNA polymerases, or if the different structural 
nature of DNA/RNA and RNA/RNA duplexes provide different thermodynamic base 
pairing parameters.   A significant obstacle that must be overcome in order to perform 
these studies is the lack of thermostable polymerases that will process the DNA/RNA and 
RNA/RNA polymerization events while maintaining the integrity of the duplex.   
 
 
∆G˚ 
Correct
  Incorporation
Misincorporation
E + DNAn+1           
E + DNAn          
E•DNAn + dNTP          
E•DNAn•dNTP 
Figure 5: A hypothetical free energy diagram, displaying the different reaction 
profiles of a correct incorporation event and an incorrect incorporation event 
for a polymerase that discriminates at the dNTP binding step.   
 
E*•DNAn•dNTP 
E*•DNAn+1•PPi 
E•DNAn+1•PPi           
E•DNAn+1 + PPi 
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Table 1. Correct and incorrect polymerization events and their associated ∆G˚ 
 
 
 
  incorporation   ∆Gº   ∆∆Gº   
Primer-Template event polymerase kcal/mol error kcal/mol error 
Primer T/DNAt 
           
TCCATATCACAT                                A → T Vent exo- -4.68 0.10    
AGGTATAGTGTATGTCTTATCATCT’ T → T Vent exo- 0.52 0.15 5.20 0.18 
Primer T/DNAt 
            
TCCATATCACAT                               ’ A → T BF -4.88 0.15    
AGGTATAGTGTATGTCTTATCATCT T → T BF 0.96 0.04 5.84 0.16 
Primer T/DNAt 
       
TCCATATCACAT                                A → T KF -4.97 0.17    
AGGTATAGTGTATGTCTTATCATCT’ T → T KF N/A N/A N/A N/A 
Primer C/DNAt 
            
TCCATATCACAC                               A → T Vent exo- -5.08 0.12    
AGGTATAGTGTGTATCTTATCATCT C → T Vent exo- -0.10 0.16 4.98 0.20 
Primer G/DNAt 
            
TCCATATCACCG                               A → T Vent exo- -5.12 0.16    
AGGTATAGTGGCTATCTTATCATCT G → T Vent exo- -0.32 0.59 4.81 0.62 
       
Primer T/DNAc 
            
TCCATATCACAT                                G → C Vent exo- -5.08 0.14    
AGGTATAGTGTACTTCTTATCATCT T → C Vent exo- -0.55 0.13 4.52 0.19 
Primer C/DNAc 
            
TCCATATCACAC                               G → C Vent exo- -5.73 0.11    
AGGTATAGTGTGCTTCTTATCATCT C → C Vent exo- 0.81 0.12 6.54 0.16 
Primer A/DNAc 
            
TCCATATCACGA                               G → C Vent exo- -6.20 0.10    
AGGTATAGTGCTCAACTTATCATCT A → C Vent exo- -0.61 0.12 5.58 0.16 
       
Primer T/DNAg 
            
TCCATATCACAT                                C → G Vent exo- -5.09 0.08    
AGGTATAGTGTAGTTCTTATCATCT T → G Vent exo- -1.57 0.79 3.52 0.80 
Primer A/DNAg 
            
TCCATATCACGA                               C → G Vent exo- -6.04 0.04    
AGGTATAGTGCTGAACTTATCATCT A → G Vent exo- 0.95 0.17 6.98 0.17 
Primer G/DNAg 
            
TCCATATCACCG                               C → G Vent exo- -5.78 0.20    
AGGTATAGTGGCGAACTTATCATCT G → G Vent exo- 0.18 0.55 5.96 0.58 
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Table 1 continued. Correct and incorrect polymerization events and their associated ∆G˚ 
  incorporation   ∆Gº   ∆∆Gº   
Primer-Template event polymerase kcal/mol error kcal/mol error 
Primer C/DNAa 
            
TCCATATCACAC                                 T → A Vent exo- -4.30 0.06    
AGGTATAGTGTGATTCTTATCATCT C → A Vent exo- 0.19 0.29 4.49 0.29 
Primer CT/DNAa 
            
TCCATATCACACT                               T → A Vent exo- -4.68 0.17    
AGGTATAGTGTGATTCTTATCATCT C → A Vent exo- -0.13 0.06 4.55 0.18 
Primer C long/DNAa 
       
CAGTCCAGCGGTGCAGTCTGCTCACAC                                  T → A Vent exo- -4.47 0.06    
GTCAGGTCGCCACGTCAGACGAGTGTGATTCTTATCATCT C → A Vent exo- -0.10 0.11 4.37 0.13 
Primer A/DNAa 
            
TCCATATCACGA                                  T → A Vent exo- -4.86 0.09    
AGGTATAGTGCTAGGCTTATCATCT  A → A Vent exo- -1.14 0.29 3.73 0.31 
Primer G/DNAa 
            
TCCATATCACCG                               T → A Vent exo- -4.63 0.08    
AGGTATAGTGGCATTCTTATCATCT G → A Vent exo- 1.52 0.27 6.15 0.28 
       
Primer C/Abasic1  
            
TCCATATCACAC                                C → _ Vent exo- 0.60 0.13 N/A N/A 
AGGTATAGTGTG_ATCTTATCATCT T → _ Vent exo- -0.38 0.07 N/A N/A 
  A → _ Vent exo- -2.36 0.09 N/A N/A 
  G → _ Vent exo- -1.89 0.11 N/A N/A 
Primer C/Abasic4  
            
TCCATATCACAC                               C → _ Vent exo- 0.87 0.08 N/A N/A 
AGGTATAGTGTG____TTATCATCT T → _ Vent exo- -0.15 0.11 N/A N/A 
  A → _ Vent exo- -2.60 0.05 N/A N/A 
  G → _ Vent exo- -2.16 0.06 N/A N/A 
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Table 2.  The effect of magnesium on ∆G˚
 incorporation for correct incorporation of dTTP 
into Primer C/DNAa. 
 
[MgCl2]  
(mM) 
∆G˚
 incorporation  
(kcal/mol) 
∆G˚misincorporation 
(kcal/mol) 
∆∆G˚incorporation 
(kcal/mol) 
6 -4.05 0.55 4.61 
8 -4.39 0.71 5.11 
10 -4.68 0.60 5.29 
12 -4.80 0.30 5.10 
14 -4.89 -1.13 3.75 
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